Outlook Therapeutics Inc
OTLK
NASDAQ
Biotechnology
$0.76
USD
-0.13 (-14.90%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $163.15M
Volume 104.4M
Price Target
$4.00 – $10.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $10.00 and a min estimate of $4.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$7.00
+$4.5 vs prior
Implied Upside
+821.0%
+592.1% vs prior
Analyst Covering
2
-1 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
40%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Julian Harrison | BTIG | Buy | Upgraded | 2 weeks ago | Plus | Plus | Plus |
Edward Woo | Ascendiant Capital | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
CUE
Cue Biopharma Inc
$34.20
▲ +10.0%
HURA
TuHURA Biosciences Inc
$2.47
▲ +7.4%
INDP
Indaptus Therapeutics Inc
$1.07
▲ +0.9%
VTVT
vTv Therapeutics Inc
$30.12
▼ -2.4%
EQ
Equillium Inc
$2.36
▲ +17.4%
UNCY
Unicycive Therapeutics Inc
$5.51
▲ +2.0%
CBUS
Cibus Inc
$1.77
▼ -6.8%
SPRB
Spruce Biosciences, Inc
$52.64
▲ +5.8%
IMDX
Insight Molecular Diagnostics Inc
$4.32
▲ +16.4%